Literature DB >> 20862604

Gene therapy for epilepsy.

David W McCandless1, Jeffrey W McCandless.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20862604     DOI： 10.1007/s11011-010-9209-7

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN： 0885-7490            Impact factor:   3.584


× No keyword cloud information.
  24 in total

1.  Quantitative analysis of the packaging capacity of recombinant adeno-associated virus.

Authors:  J Y Dong; P D Fan; R A Frizzell
Journal:  Hum Gene Ther       Date:  1996-11-10       Impact factor: 5.695

Review 2.  Neuropeptides in perspective: the last ten years.

Authors:  T Hökfelt
Journal:  Neuron       Date:  1991-12       Impact factor: 17.173

Review 3.  Current treatments of epilepsy.

Authors:  Siddhartha Nadkarni; Josiane LaJoie; Orrin Devinsky
Journal:  Neurology       Date:  2005-06-28       Impact factor: 9.910

4.  Intranasal administration of the growth-compromised HSV-2 vector DeltaRR prevents kainate-induced seizures and neuronal loss in rats and mice.

Authors:  Jennifer M Laing; Michael D Gober; Erin K Golembewski; Scott M Thompson; Kymberly A Gyure; Paul J Yarowsky; Laure Aurelian
Journal:  Mol Ther       Date:  2006-02-24       Impact factor: 11.454

5.  Powerful inhibition of kainic acid seizures by neuropeptide Y via Y5-like receptors.

Authors:  D P Woldbye; P J Larsen; J D Mikkelsen; K Klemp; T M Madsen; T G Bolwig
Journal:  Nat Med       Date:  1997-07       Impact factor: 53.440

6.  Adeno-associated virus-mediated expression and constitutive secretion of NPY or NPY13-36 suppresses seizure activity in vivo.

Authors:  S Foti; R P Haberman; R J Samulski; T J McCown
Journal:  Gene Ther       Date:  2007-08-23       Impact factor: 5.250

Review 7.  Overexpression of NPY and Y2 receptors in epileptic brain tissue: an endogenous neuroprotective mechanism in temporal lobe epilepsy?

Authors:  Annamaria Vezzani; Günther Sperk
Journal:  Neuropeptides       Date:  2004-08       Impact factor: 3.286

8.  Neuropeptide Y gene therapy decreases chronic spontaneous seizures in a rat model of temporal lobe epilepsy.

Authors:  Francesco Noè; Allan-Hermann Pool; Jari Nissinen; Marco Gobbi; Ross Bland; Massimo Rizzi; Claudia Balducci; Francesco Ferraguti; Gunther Sperk; Matthew J During; Asla Pitkänen; Annamaria Vezzani
Journal:  Brain       Date:  2008-05-13       Impact factor: 13.501

9.  Hippocampal NPY gene transfer attenuates seizures without affecting epilepsy-induced impairment of LTP.

Authors:  Andreas T Sørensen; Litsa Nikitidou; Marco Ledri; En-Ju D Lin; Matthew J During; Irene Kanter-Schlifke; Merab Kokaia
Journal:  Exp Neurol       Date:  2008-11-10       Impact factor: 5.330

10.  Recombinant AAV-mediated expression of galanin in rat hippocampus suppresses seizure development.

Authors:  En-Ju D Lin; Cristina Richichi; Deborah Young; Kristin Baer; Annamaria Vezzani; Matthew J During
Journal:  Eur J Neurosci       Date:  2003-10       Impact factor: 3.386
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.